Navigation Links
At-the-Market Offerings (ATM) of Life Sciences Companies Perform Well in Weak Follow-on Financing Environment of Third Quarter
Date:12/13/2011

NEW YORK, Dec. 13, 2011 /PRNewswire/ -- Brinson Patrick Securities Corporation, a boutique investment bank specializing in at-the-market (ATM) offerings, announced today that life sciences companies in the U.S. raised $25 million through activity of nine ATM offerings of common stock in the third quarter of this year.

While the data represent a 60 percent decrease in the use of ATMs in the life sciences sector compared to the second quarter of 2011, this reduction in gross proceeds is less than the 77 percent decline observed with more traditional follow-on financing vehicles such as registered direct, secondary and private investment in public equity (PIPE) offerings.  In addition, four new ATMs were activated in the third quarter, combining for a total of 15 new ATMs through the third quarter.

"The third quarter was a challenging fundraising period across the board for life sciences companies regardless of the fundraising vehicle employed," said Todd Wyche, founder and managing director of Brinson Patrick. "The driver for reduced ATM activity was a weak biotechnology equity market, in which the AMEX Biotechnology Index declined 26 percent during the third quarter.  However, ATMs preformed relatively well compared to conventional follow-on financings because they enable companies to remain in control of their financing activities and raise capital as needed.  We view this as further evidence of the flexibility and value of ATMs as a financing vehicle that should be included in all CFOs' toolboxes."

Life science companies that utilized ATMs to raise capital in the third quarter included AEterna Zentaris Inc., Quebec City, Quebec; OXiGENE Inc., South San Francisco; Apricus Biosciences, Inc., San Diego; and XOMA Ltd., Berkeley, Calif.

An ATM offering provides an efficient means of raising equity capital over time by enabling a publicly traded company to tap into the existing secondary market for its shares on an as-
'/>"/>

SOURCE Brinson Patrick Securities Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings
2. Simbionix Increases Product Offerings for OB/GYN Physicians
3. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
4. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
5. Model N Extends its Industry-Leading Contract Management Offerings with Contract Authoring Capabilities
6. Global Trends Drive Opportunities for Tailored Offerings, Market Partnerships and Sustainable Growth
7. Dehaier Medical Systems Extends Product Offerings with Exclusive Distribution Agreement for Penlon Anesthesia System in North China
8. CoreLab Partners Launches New DXA Imaging Service Offerings
9. Transgenomic, Inc. Enhances FAMILION® Genetic Test Offerings
10. Centrify Secures $16M in Financing to Expand Distribution and Extend Its On-Premise and Cloud Security Offerings
11. McKesson Corporation Unveils New Offerings to Empower the Community Patient Care Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  Organovo Holdings, ... company focused on delivering breakthrough 3D bioprinting technology, ... kidney tissue at the 2015 Experimental Biology conference ... "Kidney represents an ideal extension of ... can be tremendously useful in pharmaceutical research," said ...
(Date:4/1/2015)... ROCKVILLE, Md. , April 1, 2015 /PRNewswire/ ... developer of pathogen-specific therapies for serious infections and ... today announced that clinical data supporting the development ... degrade certain beta-lactam intravenous (IV) antibiotics within the ... of the gut microbiome for the prevention of ...
(Date:4/1/2015)... and NEW YORK CITY and ... a leading provider of market research reports and solutions, MarketResearch.com ... indicating that 2015 will be a year of market growth ... executives operating a stem cell company or cord blood bank, ... You must analyze market conditions, predict industry trends, and act ...
(Date:4/1/2015)... National recruitment firm Slone Partners ... as Head of Sales at Optimal Medicine, an international ... , Allen brings over 20 years experience in healthcare ... of companies including Dell Services Healthcare, Medsphere Systems and ... perfect fit for accomplishing the goals Optimal Medicine had ...
Breaking Biology Technology:Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 3Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 4Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 2Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 3Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 4MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4Slone Partners Fills Head of Sales at Optimal Medicine 2
... Masimo Corporation,(Nasdaq: MASI ), the inventor of ... to present at the Deutsche Bank 33rd,Annual Health Care ... May 6, 2008 at 9:30 a.m. ET. Joe E. ... of the presentation will be available on the Masimo ...
... first,paragraph. The timing of the live teleconference should have read: "9:00 am ... copy follows: Resverlogix ... ... is pleased to announce that it will host a live,teleconference on May 8, 2008 ...
... to Provide Unique Insights and ... SOUTH SAN FRANCISCO, May 1 Monogram,Biosciences, Inc. ... HER1,and HER3 Quantitative Protein Assays are now available for ... and,HER3 assays provide unique, quantitative measurements of protein expression,and ...
Cached Biology Technology:Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference 2/C O R R E C T I O N from Source -- Resverlogix Corp./ 2HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 2HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 3HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 4HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 5
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/20/2015)... OXFORD, Conn. , March 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... Wocket® smart wallet is one of the products featured ... today, March 20th at 11:00 PM EST on the ... travels to Las Vegas , site ...
(Date:3/17/2015)... March 17, 2015 Emotient, the leader ... today announced general availability of Emotient Analytics ... the analysis of facial expressions. The system analyzes ... content, products and services. It delivers audience response ... sentiment - as derived from facial evidence of ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... EAST LANSING, Mich. Researchers at Michigan State University ... natural killer cells fight bacterial infection and reduce inflammation, ... are fiber supplements that serve as food for the ... taken, they can stimulate the growth of the "good" ...
... PhD, research group leader at the new Max Planck ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF). ... to develop a technology that will help scientists working ... LRRK2, a Parkinson,s-related gene. Globally, five million people have ...
... presented at Europe,s leading breast cancer translational research conference ... differences between individual breast cancers. Focused on ... sensitive to important therapies, the new studies will help ... for millions of patients. "Despite major advances in ...
Cached Biology News:Researchers show prebiotic can reduce severity of colitis 2Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinson's drug development tools 2Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinson's drug development tools 3New data improve understanding of breast cancer's multiple varieties 2New data improve understanding of breast cancer's multiple varieties 3New data improve understanding of breast cancer's multiple varieties 4New data improve understanding of breast cancer's multiple varieties 5New data improve understanding of breast cancer's multiple varieties 6
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Mouse monoclonal antibody to PPP2R2C - protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform...
Mouse polyclonal antibody to BTG2 - BTG family, member 2...
...
Biology Products: